William Cheng

YIV-906 potentiated anti-PD1 action against hepatocellular carcinoma by enhancing adaptive and innate immunity in the tumor microenvironment

Caroline H. Johnson, Lieping Chen, N. Rattray, 2021, Scientific Reports.

PI4K2β constrains non-canonical Wnt-PCP signalling and is localised by PAR-1 (MARK2/3) phosphorylation

Jeremy B. A. Green, Jingjing Li, S. M. Tsang, 2019, bioRxiv.

The Evolution of Future Medicine - WE Medicine - To Meet Unmet Medical Needs

W. Lam, Fulan Guan, Shwu-Huey Liu, 2019, Novel Approaches in Cancer Study.

Mechanism Based Quality Control (MBQC) of Herbal Products: A Case Study YIV-906 (PHY906)

Wing Lam, W. Lam, Fulan Guan, 2018, Front. Pharmacol..

High throughput screening of biologically functional small molecules for modulating the expression of FGFR1OP2/wit3.0 in fibroblasts.

I. Nishimura, William Cheng, 2012, Journal of the California Dental Association.